Expand All | Contract All Empower Yourself: Free Medical/Legal Guide

Improved Survival with Interferon Alpha Maintenance Therapy Following Pleurectomy/Decortication and Radiation for Malignant Pleural Mesothelioma  
 

(As presented by Dr. Robert Cameron to the Society of Thoracic Surgeons, January 30, 2006. )

In this presentation, Dr. Cameron demonstrates that "maintenance therapy" such as interferon alpha may have a role in treating mesothelioma patients. The median survival of patients receiving interferon alpha after undergoing pleurectomy with decortication followed by surgery was 37 months.

View the publication abstract and the accompanying slides to see all of the research results by selecting any of the following:

• Interferon Alpha Abstract
• Protocol
• Radiation
• Conclusions

** POSTED AUGUST 27, 2007 **